Impact of the new definition of pre-eclampsia on the incidence and performance of first-trimester screening for the disease.
The traditional definition of preeclampsia (PE) is based on the development of hypertension and proteinuria. This has recently been revised to include cases without proteinuria but with evidence of renal, hepatic or hematological dysfunction. To examine the impact of the new definition of PE on first, the incidence and severity of the disease, and second, the performance of the competing risks model for first-trimester assessment of risk for PE. This was a retrospective study of 66,964 singleton pregnancies that were classified as PE, gestational hypertension (GH) or no PE or GH according to the traditional criteria of the International Society for the Study of Hypertension in Pregnancy (ISSHP), which defines PE by the presence of both hypertension and proteinuria. We reviewed the records of GH and those cases with high creatinine or liver enzymes or low platelet count were reclassified as PE according to the new criteria of ISSHP (ISSHP-new) and the new criteria of the American College of Obstetricians and Gynecologists (ACOG). The groups of PE according to traditional criteria and new criteria were compared for first, the gestational age at delivery, birthweight percentile and incidence of SGA neonates with birthweight <10th percentile and perinatal death, and second, the predictive performance for preterm-PE of the competing risks model based on a combination of maternal risk factors, uterine artery pulsatility index (UtA-PI), mean arterial pressure (MAP) and serum placental growth factor (PLGF) at 11-13 weeks' gestation (triple test). According to ISSHP-old 1,870 (2.8%) cases had PE, 2,182 (3.3%) had GH and 62,912 (94.0%) had no PE or GH. The incidence of PE according to ACOG was 3.0% (2,029 / 66,964) and ISSHP-new was 3.4% (2,301 / 66,964). The median gestational age at delivery for PE according to ISSHP-old (38.4 weeks) was lower than in the extra cases of PE according to AJOG (difference 1.3 weeks, 95% CI 0.71-1.71) and extra cases of PE according to ISSHP-new (difference 1.5 weeks, 95% CI 1.29-1.71). The incidence of SGA neonates in the cases of PE according to ISSHP-old (33.34%) was higher than in the extra cases of PE according to AJOG (relative risk 0.57%, 95% CI 0.42- 0.79) and extra cases of PE according to ISSHP-new (relative risk 0.52%, 95% CI 0.42- 0.65). In first-trimester screening for preterm-PE by the triple test, the detection rate, at 10% false positive rate, was 75.9%, (95% CI 70.8-80.6) for PE ISSHP-old, 74.3% (69.2-79.0) for PE AJOG and 74.0% (68.9-78.6) for PE ISSHP-new. The new definitions of PE resulted in first, an increase of pregnancies classified as PE but the additional cases had milder disease, and second, a non-significant decrease in the performance of first-trimester screening for PE. This article is protected by copyright. All rights reserved.